| 000 | 00924 a2200277 4500 | ||
|---|---|---|---|
| 005 | 20250517192122.0 | ||
| 264 | 0 | _c20180918 | |
| 008 | 201809s 0 0 eng d | ||
| 022 | _a1474-547X | ||
| 024 | 7 |
_a10.1016/S0140-6736(17)32145-1 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aTsuda, Kenji | |
| 245 | 0 | 0 |
_aTargeted-release budesonide therapy for IgA nephropathy. _h[electronic resource] |
| 260 |
_bLancet (London, England) _c12 2017 |
||
| 300 |
_a2625 p. _bdigital |
||
| 500 | _aPublication Type: Letter; Comment | ||
| 650 | 0 | 4 | _aBudesonide |
| 650 | 0 | 4 | _aGlomerulonephritis, IGA |
| 650 | 0 | 4 | _aHumans |
| 700 | 1 | _aTanimoto, Tetsuya | |
| 700 | 1 | _aMori, Jinichi | |
| 700 | 1 | _aKosugi, Kazuhiro | |
| 700 | 1 | _aKomatsu, Tsunehiko | |
| 773 | 0 |
_tLancet (London, England) _gvol. 390 _gno. 10113 _gp. 2625 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/S0140-6736(17)32145-1 _zAvailable from publisher's website |
| 999 |
_c27904533 _d27904533 |
||